Company: BGLC
Filing Date: 2025-02-27
Form Type: DEF 14A
Source: 0001477932-25-001335
Chunk: 0

Company: BioNexus Gene Lab Corp
Filing Date: 2025-02-27
Form: DEF 14A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 14A

PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE

SECURITIES EXCHANGE ACT OF 1934</div>

|   | Filed by the Registrant ☒  Filed by a party other than the Registrant ☐  Check the appropriate box: |
| ☐ | Preliminary Proxy Statement                                                                         |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))                     |
| ☒ | Definitive Proxy Statement                                                                          |
| ☐ | Definitive Additional Materials                                                                     |
| ☐ | Soliciting Material under §240.14a-12                                                               |

| BioNexus Gene Lab Corp.                          |
| (Name of Registrant As Specified In Its Charter) |

<div align='center'>(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</div>

|   | Payment of Filing Fee (Check the appropriate box):                                                   |
| ☒ | No fee required.                                                                                     |
| ☐ | Fee paid previously with preliminary materials.                                                      |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a–6(i)(1) and 0–11. |

<div align='center'>BIONEXUS GENE LAB CORP.

NOTICE OF SPECIAL MEETING OF STOCKHOLDERS

TO BE HELD ON March 19, 2025</div>

Notice is hereby given that a Special Meeting of Stockholders (the “Special Meeting”) of BioNexus Gene Lab Corp. will be held on March 19, 2025, at 1:00 p.m., Eastern Time, at the virtual meeting site www.bionexusgenelab.com/2025specialmeeting. The Special Meeting will be held solely online, and as such there is no physical address for the Special Meeting. The Special Meeting will be held for the following purposes as more fully described in the proxy statement accompanying this notice (the “Proxy Statement”):

| 1. | Reverse Stock Split Proposal. Approval of an amendment to our Articles of Incorporation to effect a reverse stock split of our outstanding shares of common stock, no par value, at a ratio, ranging from one-for-five (1:5) to one-for-ten (1